BRCA1 mutations and other sequence variants in a population-based sample of Australian women with breast cancer (original) (raw)

References

• Bishop, D. T. & Hopper, J. L. (1997). AT-tributable risks?. Nature Genet 15: 226
  Article CAS PubMed Google Scholar
• Claus, E. B., Risch, N. & Thompson, W. D. (1991). Genetic analysis of breast cancer in the Cancer and Steroid Hormone Study. Am J Hum Genet 48: 232–242.
  CAS PubMed PubMed Central Google Scholar
• Clayton, D. & Hills, M. (1993). Statistical Models in Epidemiology. Oxford: Oxford University Press
• Durocher, F., Shattuck-Eidens, D., McClure, M., Labrie, F., Skolnick, M. H., Goldgar, D. E. & Simard, J. (1996). Comparison of BRCA1 polymorphisms, rare sequence variants and/or missense mutations in unaffected and breast/ovarian cancer populations. Hum Mol Genet 5: 835–842.
  Article CAS PubMed Google Scholar
• Easton, D. (1997). Breast cancer genes – what are the real risks?. Nature Genet 16: 210–211.
  Article CAS PubMed Google Scholar
• Easton, D. F., Bishop, D. T., Ford, D. & Crockford, G. P., the Breast Cancer Linkage Consortium (1993). Genetic linkage analysis in familial breast and ovarian cancer: results from 214 families. Am J Hum Genet 52: 678–701.
  CAS PubMed PubMed Central Google Scholar
• Easton, D. F., Mathews, F. E. & Ford, D. (1996). Cancer mortality in relatives of women with ovarian cancer: the OPCS study. Int J Cancer 65: 284–294.
  Article CAS PubMed Google Scholar
• Ford, D., Easton, D. F., Bishop, D. T., Narod, S. A. & Goldgar, D. E., the Breast Cancer Linkage Consortium (1994). Risks of cancer in _BRCA1_-mutation carriers. Breast Cancer Linkage Consortium. Lancet 343: 692–695.
  Article CAS PubMed Google Scholar
• Ford, D., Easton, D. F. & Peto, J. (1995). Estimates of the gene frequency of_BRCA1_and its contribution to breast and ovarian cancer incidence. Am J Hum Genet 57: 1457–1462.
  CAS PubMed PubMed Central Google Scholar
• Friedman, L. S., Ostermeyer, E. A., Szabo, C. I., Dowd, P., Lynch, E. D., Rowell, S. E. & King, M. C. (1994). Confirmation of BRCA1 by analysis of germline mutations linked to breast and ovarian cancer in ten families. Nature Genet 8: 399–404.
  Article CAS PubMed Google Scholar
• Hacia, J. G., Brody, L. C., Chee, M. S., Fodor, S. P. & Collins, F. S. (1996). Detection of heterozygous mutations in BRCA1 using high density oligonucleotide arrays and two-colour fluorescence analysis. Nature Genet 14: 441–447.
  Article CAS PubMed Google Scholar
• Hogervorst, F. B., Cornelis, R. S., Bout, M., Van Vliet, M., Oosterwijk, J. C., Olmer, R., Bakker, B., Klijn, J. G., Vasen, H. F. & Meijers Heijboer, H. (1995). Rapid detection of BRCA1 mutations by the protein truncation test. Nature Genet 10: 208–212.
  Article CAS PubMed Google Scholar
• Hopper, J. L. & Carlin, J. B. (1992). Familial aggregation of a disease consequent upon correlation between relatives in a risk factor measured on a continuous scale. Am J Epidemiol 136: 1138–1147.
  Article CAS PubMed Google Scholar
• Hopper, J. L., Giles, G. G., McCredie, M. R. E. & Boyle, P. (1994). Background, rationale and protocol for a case–control-family study of breast cancer. Breast 3: 79–86.
  Article Google Scholar
• Langston, A. A., Malone, K. E., Thompson, J. D., Daling, J. R. & Ostrander, E. A. (1996). BRCA1 mutations in a population-based sample of young women with breast cancer. New Engl J Med 334: 137–142.
  Article CAS PubMed Google Scholar
• McCredie, M. R. E., Dite, G. S., Giles, G. G. & Hopper, J. L. (1998). Breast cancer in Australian women under the age of 40. Cancer Causes Control 9: 189–198.
  Article CAS PubMed Google Scholar
• Miki, Y., Swensen, J., Shattuck-Eidens, D., Futreal, P. A., Harshman, K., Tavtigian, S., Liu, Q., Cochran, C., Bennett, L. M., Ding, W., Bell, R., Rosenthal, J., Hussey, C., Tran, T., McClure, M., Frye, C., Hattier, T., Phelps, R., Haugenstrano, A., Katcher, H., Yakumo, K., Gholami, Z., Shaffer, D., Stone, S., Bayer, S. & Skolnick, M. (1994). A strong candidate for the 17q-linked breast and ovarian cancer susceptibility gene BRCA1. Science 266: 66–71.
  Article CAS PubMed Google Scholar
• Newman, B., Mu, H., Butler, L. M., Millikan, R. C., Moorman, P. G. & King, M-C (1998). Frequency of breast cancer attributable to BRCA1 in a population-based series of European–American and African–American women. JAMA 279: 915–921.
  Article CAS PubMed Google Scholar
• Peto, J., Easton, D. F., Mathews, F. E., Ford, D. & Swerdlow, A. J. (1996). Cancer mortality in relatives of women with breast cancer: the OPCS study. Int J Cancer 65: 275–283.
  Article CAS PubMed Google Scholar
• Roest, P. A., Roberts, R. G., Sugino, S., van Ommen, G. J. & den Dunnen, J. T. (1993). Protein truncation test (PTT) for rapid detection of translation-terminating mutations. Hum Mol Genet 2: 1719–1721.
  Article CAS PubMed Google Scholar
• Shattuck-Eidens, D., McClure, M., Simard, J., Labrie, F., Narod, S., Couch, F., Hoskins, K., Weber, B., Castilla, L., Erdos, M., Brody, L., Friedman, L., Ostermeyer, E., Szabo, C., King, M. C., Jhanwar, S., Offit, K., Norton, L., Gilewski, T., Lubin, M., Osborne, M., Black, D., Boyd, M., Steel, M., Ingles, S. & Goldgar, D. E. (1995). A collaborative survey of 80 mutations in the BRCA1 breast and ovarian cancer susceptibility gene. Implications for presymptomatic testing and screening. JAMA 273: 535–541.
  Article CAS PubMed Google Scholar
• Simard, J., Tonin, P., Durocher, F., Morgan, K., Rommens, J., Gingras, S., Samson, C., Leblanc, J. F., C, B. & Dion, F. (1994). Common origins of BRCA1 mutations in Canadian breast and ovarian cancer families. Nature Genet 8: 392–398.
  Article CAS PubMed Google Scholar
• Southey, M. C., Batten, L. E., McCredie, M. R. E., Giles, G. G., Dite, G., Hopper, J. L. & Ventor, D. J. (1998). Estrogen receptor polymorphism at codon 325 and risk of breast cancer before the age of 40. J Natl Cancer Inst 90: 532–536.
  Article CAS PubMed Google Scholar
• Struewing, J. P., Hartge, P., Wacholder, S., Baker, S. M., Berlin, M., McAdams, M., Timmerman, M. M., Brody, L. C. & Tucker, M. A. (1997). The risk of cancer associated with the 185delAG and 5382insC mutations of BRCA1 and the 6174delT mutation of BRCA2 among Ashkenazi Jews. New Engl J Med 336: 1401–1408.
  Article CAS PubMed Google Scholar
• Whittemore, A. S., Gong, G. & Itnyre, J. (1997). Prevalence and contribution of BRCA1 mutations in breast cancer and ovarian cancer: results from three US population-based case–control studies of ovarian cancer. Am J Hum Genet 60: 496–504.
  CAS PubMed PubMed Central Google Scholar
• Wooster, R., Bignell, G. & Lancaster, J.et al (1995). Identification of the breast cancer susceptibility gene BRCA2 . Nature 378: 789–792.
  Article CAS PubMed Google Scholar

Download references